{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-018313","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2025-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.807399+00:00","generated_at":"2026-05-18T08:51:04.590137+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Palisade Bio appoints Emil Chuang to board; Fischbein resigns","bullets":["Margery Fischbein resigned from board effective July 2, 2025; no disagreement with company.","Board accelerated vesting of Fischbein's 3,100 outstanding stock options to fully vested.","Emil Chuang, MB BS FRACP, appointed to board effective July 7, 2025; also joins audit, compensation, governance committees.","Chuang is a pediatric gastroenterologist with nearly 25 yrs experience, contributed to two NDA/sBLA approvals.","Chuang granted non-statutory stock option to purchase 8,000 shares at closing price on grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-018313","json":"https://secwatch.observer/filing/0001641172-25-018313.json","markdown":"https://secwatch.observer/filing/0001641172-25-018313.md","text":"https://secwatch.observer/filing/0001641172-25-018313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/0001641172-25-018313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000164117225018313/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T08:51:04.590137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}